Profile data is unavailable for this security.
About the company
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
- Revenue in USD (TTM)4.28bn
- Net income in USD906.00m
- Incorporated2000
- Employees7.80k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cognex Corporation | 1.02bn | 295.69m | 12.17bn | 2.06k | 41.84 | 8.15 | 38.31 | 11.97 | 1.65 | 1.65 | 5.66 | 8.44 | 0.4948 | 3.90 | 7.26 | 494,719.20 | 14.39 | 15.26 | 15.54 | 16.42 | 74.10 | 74.70 | 29.08 | 28.72 | 3.58 | -- | 0.00 | 48.98 | 11.77 | 12.48 | -13.58 | 10.35 | -14.26 | 16.47 |
| Bio-Rad Laboratories, Inc. | 2.98bn | 6.66bn | 17.94bn | 8.00k | 2.71 | 1.17 | 2.64 | 6.02 | 220.42 | 220.42 | 98.67 | 512.48 | 0.1864 | 2.04 | 7.27 | 372,451.90 | 41.65 | 19.81 | 43.90 | 21.90 | 57.89 | 55.00 | 223.47 | 52.39 | 2.89 | -- | 0.0008 | 0.00 | 10.12 | 4.74 | 116.43 | 102.03 | -2.45 | -- |
| Waters Corporation | 2.74bn | 694.92m | 19.80bn | 7.40k | 29.10 | 67.22 | 23.94 | 7.24 | 11.15 | 11.15 | 43.91 | 4.83 | 0.9443 | 3.15 | 5.33 | 369,740.90 | 23.98 | 14.11 | 31.58 | 16.48 | 58.84 | 58.63 | 25.40 | 23.98 | 1.89 | 27.18 | 0.8453 | 0.00 | -1.71 | 2.98 | -11.44 | 2.15 | 10.85 | -- |
| PerkinElmer, Inc. | 5.06bn | 1.13bn | 22.31bn | 14.00k | 17.59 | 3.21 | 15.60 | 4.41 | 10.05 | 10.05 | 44.71 | 55.14 | 0.4647 | 3.76 | 5.79 | 361,246.40 | 10.42 | 5.78 | 11.70 | 6.76 | 57.92 | 50.19 | 22.41 | 12.11 | 1.40 | 21.85 | 0.4231 | 9.24 | 31.18 | 12.44 | 215.92 | 30.99 | 22.39 | 0.00 |
| Avantor Inc | 7.27bn | 465.60m | 22.64bn | 12.40k | 47.25 | 7.30 | 26.87 | 3.11 | 0.7863 | 0.7863 | 12.30 | 6.74 | 0.6568 | 6.14 | 6.54 | 586,241.90 | 4.79 | -- | 5.39 | -- | 33.52 | -- | 7.29 | -- | 2.06 | 4.65 | 0.5765 | -- | 5.85 | -- | 115.52 | -- | -- | -- |
| Fortive Corp | 4.60bn | 1.66bn | 25.90bn | 17.00k | 15.61 | 2.78 | 13.08 | 5.63 | 4.63 | 4.45 | 13.09 | 25.98 | 0.2858 | 3.23 | 4.51 | 270,464.70 | 10.62 | 6.17 | 13.02 | 7.52 | 58.94 | 53.39 | 37.17 | 15.52 | 0.6687 | -- | 0.231 | 12.05 | 1.54 | -5.59 | 594.73 | 9.87 | -8.82 | -- |
| AMETEK, Inc. | 5.24bn | 929.40m | 32.12bn | 16.50k | 34.74 | 4.90 | 26.57 | 6.13 | 4.00 | 4.00 | 22.54 | 28.35 | 0.4741 | 5.17 | 6.83 | 317,679.80 | 8.41 | 8.59 | 9.74 | 9.97 | 34.73 | 36.56 | 17.73 | 15.88 | 0.8098 | 15.70 | 0.2881 | 16.31 | -11.99 | 2.70 | 1.29 | 8.11 | 1.44 | 14.87 |
| Keysight Technologies Inc | 4.94bn | 894.00m | 33.03bn | 14.30k | 37.73 | 8.67 | 27.83 | 6.68 | 4.78 | 4.78 | 26.42 | 20.80 | 0.6588 | 2.44 | 7.37 | 345,524.50 | 11.92 | 7.68 | 14.18 | 9.25 | 62.11 | 58.17 | 18.09 | 11.73 | 2.34 | 14.45 | 0.3213 | 0.00 | 17.06 | 11.11 | 42.58 | 21.69 | 13.84 | -- |
| Mettler-Toledo International Inc. | 3.62bn | 754.41m | 33.77bn | 16.50k | 46.05 | 212.15 | 39.28 | 9.33 | 31.90 | 31.90 | 153.04 | 6.92 | 1.21 | 4.44 | 6.43 | 219,313.70 | 25.26 | 20.08 | 35.86 | 27.77 | 58.68 | 57.77 | 20.85 | 17.62 | 0.8634 | 23.84 | 0.9141 | 0.00 | 2.54 | 5.19 | 7.42 | 11.31 | 2.31 | -- |
| Agilent Technologies Inc | 6.32bn | 1.21bn | 42.41bn | 17.00k | 35.66 | 7.87 | 27.70 | 6.71 | 3.94 | 3.94 | 20.57 | 17.84 | 0.6216 | 3.76 | 5.72 | 371,705.90 | 11.90 | 10.05 | 14.11 | 11.99 | 53.92 | 53.95 | 19.15 | 17.37 | 1.74 | 18.22 | 0.3362 | 22.52 | 18.36 | 8.50 | 68.29 | 21.24 | 6.34 | 11.36 |
| Roper Technologies Inc | 5.77bn | 1.12bn | 46.67bn | 18.40k | 42.04 | 4.12 | 27.81 | 8.09 | 10.53 | 10.53 | 54.28 | 107.53 | 0.2436 | 9.79 | 6.15 | 313,630.40 | 4.38 | 6.40 | 4.92 | 7.21 | 66.99 | 63.09 | 18.00 | 20.68 | 0.7692 | 6.37 | 0.4234 | 17.17 | 2.99 | 9.06 | -46.28 | 6.41 | 6.16 | 15.44 |
| Emerson Electric Co. | 18.24bn | 2.30bn | 56.74bn | 86.70k | 24.80 | 5.72 | 17.22 | 3.11 | 3.83 | 3.83 | 30.30 | 16.59 | 0.7663 | 5.37 | 5.40 | 210,334.50 | 9.78 | 9.72 | 13.12 | 13.58 | 41.47 | 42.13 | 12.76 | 12.03 | 1.02 | 21.13 | 0.4018 | 59.58 | 8.64 | 4.66 | 17.20 | 7.69 | 5.38 | 1.23 |
| Illumina, Inc. | 4.28bn | 906.00m | 60.08bn | 7.80k | 63.35 | 5.70 | 53.73 | 14.04 | 6.07 | 6.07 | 28.77 | 67.47 | 0.381 | 3.22 | 8.01 | 548,717.90 | 8.07 | 12.55 | 8.87 | 15.33 | 69.30 | 68.66 | 21.17 | 24.21 | 2.24 | -- | 0.1374 | 0.00 | -8.58 | 7.85 | -34.53 | 7.28 | 5.74 | -- |
Data as of Jan 20 2022. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
42.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 30 Sep 2021 | 20.63m | 13.20% |
| The Vanguard Group, Inc.as of 30 Sep 2021 | 11.24m | 7.19% |
| BlackRock Fund Advisorsas of 30 Sep 2021 | 7.10m | 4.54% |
| Edgewood Management LLCas of 30 Sep 2021 | 6.91m | 4.42% |
| SSgA Funds Management, Inc.as of 30 Sep 2021 | 5.95m | 3.81% |
| Wellington Management Co. LLPas of 30 Sep 2021 | 3.27m | 2.09% |
| Loomis, Sayles & Co. LPas of 30 Sep 2021 | 3.20m | 2.05% |
| Geode Capital Management LLCas of 30 Sep 2021 | 2.62m | 1.68% |
| Polen Capital Management LLCas of 30 Sep 2021 | 2.54m | 1.62% |
| Walter Scott & Partners Ltd.as of 30 Sep 2021 | 2.48m | 1.59% |
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
